Feedback on challenges and innovations
A look back at 2022 innovation challenges and highlights for oral solid dosage forms, this podcast episode will review insights from industry experts on the factors driving the evolution of OSD forms as well as innovations in APIs, technology and methodology. Highlights include expert commentary from LGM Pharma, Hovione, Syntegon and Colorcon.
About the speakers
Deepak Thassu, Vice President R&D and Regulatory Submissions, LGM Pharma, joined LGM in 2020 to lead the company’s integrated R&D and Regulatory Submissions teams for CDMO clients. He launched commercial products with several US and European patents and managed submissions for NDAs, ANDAs, BLAs and medical devices. Prior to joining Nexgen in 2015 to lead the R&D and Regulatory groups, Deepak was Managing Director at Actavis, Chief Scientific Officer and Vice President of Pharmaceutical Development at PharmaNova, Chief Scientific Officer and Senior Vice President of Pharmaceutical Development at Holopack International, and Associate Director of global pharmaceutical development and technology at UCB Pharma. He received his Masters in Pharmacy from the University of Saugor and his Ph.D. and postgraduate training from the University of Cincinnati in Pharmaceutical Sciences. He earned MBAs from Cornell University, in General Business Administration and Finance, and Queen’s University.
Marco Gil, senior vice president of sales and marketing, Hovione, graduated from the chemical engineering department of the Technical University of Lisbon, where he also obtained a doctorate in chemistry in 2006. In 2007, he joined the R&D department of Hovione as a particle scientist. design disciplines. The focus of his work was the application of particle engineering technologies to improve the bioavailability of poorly water-soluble drugs. In May 2011, he was appointed Director of R&D Process Chemistry and was responsible for a group of scientists dedicated to the development and scale-up of chemical processes for the production of active ingredients. He held several management responsibilities, including General Manager of Hovione’s US site operations and trade-related functions. He is the author of more than 15 scientific articles in peer-reviewed journals and book chapters, co-author of two patents and invited speaker at more than 10 international conferences.
Alex Trombley, Head of Business Development for the Huttlin Wallet Line at Syntegon. He spent five years at Eli Lilly and Co. working on formulation and process development work for oral solid dosage forms before joining Syntegon in 2021. Trombley has experience developing early-stage formulations , process identification, scale-up and technology transfer and has worked extensively with continuous manufacturing, high shear granulation, fluidized bed granulation, compression and coating. At Syntegon, he focuses on technical support, customer trials and market development for Huttlin products in North America. He studied chemical engineering with a minor in computer science at the University of Michigan.
Gary’s Pond is the Global Head of Authentication for Colorcon and is responsible for leading the overall strategy, business planning and operational execution of Colorcon’s in-dose authentication business. Pond has over 25 years of experience in product management, marketing, operations, and digital transformation, and is a recognized leader in on-dose authentication. Prior to Colorcon, Pond held senior marketing and operational positions at Sanofi, Merck & Co, Abraxis Bioscience and IQVIA.
Ali Rajabi-Siahboomi is vice president and chief innovation officer at Colorcon, based at global headquarters in the United States. Rajabi-Siahboomi held various academic positions at JM Universities of Nottingham and Liverpool in the UK before joining Colorcon as Technical Director, responsible for Europe, Middle East and Africa in 2000. His Major research interests are pharmacy in solid dosage form, pharmaceutical technology with emphasis on oral drug delivery systems, solubility enhancement to improve bioavailability and consistency of drugs and formulations of bioequivalence. He has published over 300 articles, book chapters, abstracts and patents and earned his B.Pharm. and Doctor of Pharmacy from the University of Nottingham (UK).
About the Drug Solutions Podcast
Pharmaceutical technology features the Drug Solutions podcast, where editors will chat with industry experts from across the pharmaceutical and biopharmaceutical supply chain. Join us as experts share their insights on your biggest questions, from technologies to strategies to regulations related to drug development and manufacturing.
Listen to this podcast on SoundCloud, Spotify, Google Podcasts or Apple Podcasts.